Pharmaceutical industry news

Training and events: UKHSA Knowledge and Library Services

Knowledge and Library Services provide a range of information skills training for eligible staff. Tr...

Hanmi Pharmaceutical signs record $2.3 bn obesity drug licensing deal with Roche’s Genentech

IFPI 2026 Programme Architecture Unveiled

Roche pens $2.5B pact for Hanmi’s clinical-stage obesity drug targeting less-explored mechanism

Competition for obesity treatments is shifting from "how much do you lose" to "how do you lose?" If

China Resources Pharmaceutical Group: Revenue up 2.0% YoY to RMB134.5B; net profit RMB5.02B; interim dividend up 21%

As Hanmi Pharmaceutical has achieved the feat of exporting up to $2.3 billion (about 3.1723 trillion..

Enterprise value to revenue forward of Extrawell Pharmaceutical Holdings Limited – HKEX:858

newsGP - Optimism around ‘personalised’ melanoma treatment

Novo Nordisk to test zenagamtide against its own semaglutide in Korea

CT-based biotech TECLens aims to make reading glasses optional

Three killed in suspected sulphur dioxide leak at Karnataka pharmaceutical plant

Hanmi's 3.2T Won Muscle-Preserving Obesity Drug Tech Export

Re-engineering pharmaceutical packaging for PPWR compliance

World Health Expo to showcase trillion-dollar growth across pharma, biotech, longevity and wellness at 2027 edition

Growth of Danish pharma industry cannot be taken for granted

FSS to hold briefings on revised pharma, biotech disclosure rules

Intellectual property (IP) guidance for the NHS in England

This guidance provides practical steps, good practice principles, case studies and model agreements...

China Resources Sanjiu Medical & Pharmaceutical's Attributable Profit Slides 8% in H1

Samjin Pharm seeks government dementia-friendly certification

Psilocybin Works in the Lab. Can It Survive the Clinic?

In order to support the on-site settlement of the pharmaceutical and bio disclosure improvement plan..

Olix Completes Phase 1b Trial of Hair Loss Treatment OLX104C in Australia; Phase 2a to Begin Within Year

National Norovirus and Rotavirus Report, week 35 report: data to week 34 (data up to 23 August 2026)

Summary of norovirus and rotavirus laboratory surveillance and enteric virus outbreaks in England du...

Monthly mandatory surveillance of MRSA, MSSA, Gram-negative bacteraemia and C. difficile infections, July 2025 to July 2026

Mandatory surveillance of healthcare-associated infections (HCAI), which include methicillin-resista...

Ribomic Completes Site Network for Phase 3 Achondroplasia Trial in Japan

Jemperli (dostarlimab) accepted for priority review by the US FDA for dMMR/MSI-H locally advanced rectal cancer

Hibsago (bepirovirsen) approved in Japan as first and only functional cure for chronic hepatitis B

Series SEA: Who’s investing in the region’s biotech startups?

Hanmi Pharm shares surge 30% after $2.3 bil. Genentech obesity drug deal

Hanmi Licenses Obesity Drug To Genentech

ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1

China Biotech’s Global Breakout: Innovation, Deals and the Next Investment Cycle

Hanmi Pharm signs $2.3 bil . licensing deal with Roche's Genentech for obesity drug candidate

CSPC Pharmaceutical Group Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Phase 3 LUCIDITY Trial Success Puts Avexitide on Track to Become First PBH Treatment

2 GLP-1 Stocks That Could Double Your Money by 2031

Hanmi Pharm signs 3.2 tln-won licensing deal with Roche's Genentech for obesity drug candidate

Cabinet to focus on biotech through policy, technology: Premier-News-Radio Taiwan International

Nomura raises target price for CSPC Pharmaceutical (01177.HK) to HK$8.67, maintains "Buy" rating

Hanmi signs obesity drug deal with Genentech worth up to $2.3 billion

Rat In Food Allegation Rocks Nalasopara Eatery; Viral Video Sparks Outrage, Residents Demand Immediate FDA

Taiwan premier touts biotech growth at annual policy meeting

Hanmi Pharm signs massive licensing deal with US biotech firm for obesity drug

Samjin Pharm seeks government dementia-friendly certification

Director Kunal Kohli wants Tukaram Mundhe to raid home kitchens. Here's why

As Hanmi Pharmaceutical succeeded in exporting the largest new drug technology since the death of it..

newsGP - Optimism around ‘personalised’ melanoma treatment

Health ministry revokes AstraZeneca Vietnam’s pharmaceutical business certificate

Jordan FDA Warns of Severe Health Violations in School Canteens, Threatens Judicial Action

With the obesity treatment craze sweeping the world, the pharmaceutical bio industry has already beg..

Hanmi signs record $2.3b obesity drug deal with Genentech

Hanmi Pharmaceutical Sets New Milestone with 3.2 Trillion Won Technology Export... Spotlight on Im Juhyun's Leadership

Silicone Tubing for Pharmaceutical Transfer Market to Reach Index 190 by 2035 on Single-Use Bioprocessing Demand

Alvotech signs agreement with Lotus Pharmaceutical

Hanmi Pharm Signs Exclusive Licensing Deal with Genentech for Novel Obesity Therapy

Hanmi Pharm Signs Exclusive Licensing Deal with Genentech for Novel Obesity Therapy

After restaurant raids, Hum Tum director Kunal Kohli wants FDA chief Tukaram Mundhe to inspect Indian home

FSS launches briefings to enforce Korea biotech disclosure reforms - CHOSUNBIZ

How bad is the food safety situation in India? | Tukaram Mundhe Interview